RxDoctor Payments Data

Andrew Barranco, DO

Physical Medicine & Rehabilitation · Birmingham, ALNPI 1639512635

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by Johnson & Johnson at 47.5% of the total. Reporting peaked in 2021 at $138 and has fallen 66.0% since, to $47 in 2024. That places this record below the midpoint for physical medicine & rehabilitation clinicians in AL, where the typical reported total is $434.

$439in general payments, 2019–2025

Across 20 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$209
  • Pfizer$197
  • E.r. Squibb & Sons, L.L.C.$20
  • AbbVie$13

What the payments were for

  • Food & beverage$439100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson8$209
Pfizer10$197
E.r. Squibb & Sons, L.L.C.1$20
AbbVie1$13

How this compares

$439 in reported general payments places this provider in the 50th percentile of 104 physical medicine & rehabilitation providers in Alabama.

See all physical medicine & rehabilitation providers in Alabama

Medicare billing

Part B allowed, 2024
$204,356
Medicare patients
363
Services billed
2,582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$31,106
Atorvastatin Calcium99$820
Ondansetron OdtOndansetron23$539
Potassium Chloride26$499
Gabapentin59$479
Pantoprazole Sodium67$468
Levetiracetam19$454
Tamsulosin Hcl46$313
Amlodipine Besylate66$305
Propranolol Hcl12$265
Levothyroxine Sodium36$263
Metoprolol Succinate28$240
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$237
Mirtazapine22$216
Fluticasone Propionate15$213

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$197$31,10654 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 104 physical medicine & rehabilitation providers in Alabama.

Other physical medicine & rehabilitation in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →